Drug intelligence / Profile preview

leukoreduced donor whole blood

Development stage
Unknown
Lead developer
Vanderbilt University Medical Center
Modality
Cell Therapies
Administration
Intravenous
01

Overview

Leukoreduced donor whole blood refers to a specific blood product derived from a deceased solid organ donor, intended for transfusion into the recipient of that donor's liver during transplantation. Developed and studied by Vanderbilt University Medical Center, this approach utilizes up to four units of the donor's own whole blood, which has been filtered to remove white blood cells (leukoreduced). The primary objective is to provide a balanced ratio of red blood cells, plasma, and platelets from a single source (the organ donor) to maintain hemodynamic stability and coagulation during the high-blood-loss environment of liver surgery, potentially reducing exposure to multiple allogenic banked blood donors and improving clinical outcomes.

Other names
Donor BloodSolid organ donor whole bloodLeukoreduced whole blood

Beyond the preview

Go deeper on leukoreduced donor whole blood.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on leukoreduced donor whole blood.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call